Literature DB >> 29664382

Fatal Visceral Leishmaniasis Caused by Leishmania infantum, Lebanon.

Rana El Hajj, Hiba El Hajj, Ibrahim Khalifeh.   

Abstract

Visceral leishmaniasis, a fatal disease if not treated, is caused by Leishmania parasites. This disease might be overlooked in the Middle East because of limited awareness and low incidence. We report 5 patients who died of visceral leishmaniasis in Lebanon and make recommendations to improve faster diagnosis and treatment.

Entities:  

Keywords:  Lebanon; Leishmania infantum; Middle East; cutaneous leishmaniasis; parasites; visceral leishmaniasis; zoonoses

Mesh:

Year:  2018        PMID: 29664382      PMCID: PMC5938785          DOI: 10.3201/eid2405.180019

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Leishmaniasis is a parasitic disease characterized by different clinical manifestations depending on patient immune response and causative species (). Visceral leishmaniasis, the most severe form, is fatal if untreated (). This disease is caused by Leishmania donovani, which is endemic to Africa and Asia, causes anthroponotic visceral leishmaniasis, and is associated with high mortality rates (). However, L. infantum, which undergoes zoonotic transmission, is associated with fewer deaths and is endemic to Latin America and the Middle East (). This species shows a mortality rate of 6% for children (). In the Middle East, cutaneous leishmaniasis is the most common endemic form of leishmaniasis and is caused mainly by L. tropica and L. major (). L. infantum is reported to cause cutaneous leishmaniasis and visceral leishmaniasis in Syria, but only cutaneous leishmaniasis in Lebanon (,). During 1958–2014, visceral leishmaniasis showed a low incidence in Syria; 17 cases were reported in 2008 and 36 cases in 2014 (,). However, no molecular or biochemical typing was performed to identify the causative species and strains (). Moreover, visceral leishmaniasis caused by L .infantum has not been reported in Lebanon (). Recently, displacement of refugees during the ongoing crisis in Syria resulted in a massive population migration and spread of communicable diseases, including cutaneous leishmaniasis (,). In Lebanon, 2,420 families from Syria were given a diagnosis of cutaneous leishmaniasis. As of April 2017, a total of 2,057 (85%) of these families were infected with L. tropica and 363 (15%) with L. major (). These infections indicate the need for early diagnosis of visceral leishmaniasis and prevention of deaths in the Middle East. We report visceral leishmaniasis in refugees from Syria in Lebanon who acquired L. infantum in Syria.

The Study

Five refugee children from Syria (age range 2–11 years) died of visceral leishmaniasis during 2014–2017 because of a late diagnosis and lack of awareness of this disease in Lebanon. All 5 children had migrated from the northern coast of Syria to Lebanon and had resided in Beirut for an average of 9 months (range 7–11 months). Visceral leishmaniasis developed 4–6 months after they left Syria. Further investigations showed that the siblings of 3 of these patients were infected while staying in Syria. All patients visited medical institutions in Lebanon and had fever, abdominal distension, ascites, hepatosplenomegaly, and pancytopenia (Table). Three patients were given incorrect diagnoses of leukemia and were given steroids and blood transfusions. The remaining 2 patients were given incorrect diagnoses of a hemophagocytic syndrome with an idiopathic etiology and treated accordingly.
Table

Clinical characteristics of 5 patients with visceral leishmaniasis, Lebanon, 2014−2017*

Patient no.Age, y/sexAbdominal distensionHepatosplenomegalyFeverAscitesBloodLung infiltratesInsect biteDelay in diagnosis, mo
111/F++++Pancytopenia++4
27/M++++Pancytopenia+5
25/M++++Pancytopenia+6
44/M++++Pancytopenia+5
52/ F++++Pancytopenia+4

*−, negative; +, positive.

*−, negative; +, positive. These 5 patients were then reevaluated at the American University of Beirut Medical Center (Beirut, Lebanon) after an average of 4.8 months. Microscopic examination of bone marrow aspirates and smear specimens showed a few scattered amastigotes within macrophages for 2 patients (Figure).
Figure

Bone marrow smear sample (A) and bone marrow aspirate (B) for patient 2 with visceral leishmaniasis caused by Leishmania infantum, Lebanon. Arrows show amastigotes within macrophages. Panel A, Wright Giemsa stain, original magnification x400; panel B, hematoxylin and eosin stain, original magnification x200.

Bone marrow smear sample (A) and bone marrow aspirate (B) for patient 2 with visceral leishmaniasis caused by Leishmania infantum, Lebanon. Arrows show amastigotes within macrophages. Panel A, Wright Giemsa stain, original magnification x400; panel B, hematoxylin and eosin stain, original magnification x200. A diagnosis of visceral leishmaniasis caused by L. infantum was confirmed by PCR amplification of the internal transcribed spacer 1 region of the parasite (), followed by restriction fragment length polymorphism analysis of the internal transcribed spacer 1 region amplicon (). This analysis specifically distinguishes L. infantum from other Leishmania species. After confirmation of visceral leishmaniasis, the patients were treated with Abelcet (amphotericin B lipid complex) (Teva Pharma BV, Harlow, UK) according to the manufacturer’s guidelines. However, the delay in diagnosis led to an advance disease stage and lack of response to treatment, followed by death.

Conclusions

We report 5 children among refugees from Syria in Lebanon who died of visceral leishmaniasis caused by L. infantum. Our report provides insightful baseline information about knowledge, practices, and control regarding this disease. The combination of hepatosplenomegaly, fever, and pancytopenia should raise the suspicion for visceral leishmaniasis and result in prompt intervention. These interventions might prevent misdiagnosis and enable appropriate treatment strategies at early stages of the disease to reduce the number of deaths.
  13 in total

1.  Isoenzyme characterization of Leishmania isolates from Lebanon and Syria.

Authors:  K N Knio; E Baydoun; R Tawk; N Nuwayri-Salti
Journal:  Am J Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.345

Review 2.  Immunopathogenesis of infection with the visceralizing Leishmania species.

Authors:  Mary E Wilson; Selma M B Jeronimo; Richard D Pearson
Journal:  Microb Pathog       Date:  2005-04       Impact factor: 3.738

3.  The epidemiology of leishmaniases in Lebanon.

Authors:  N Nuwayri-Salti; E Baydoun; R el-Tawk; R Fakhoury Makki; K Knio
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Mar-Apr       Impact factor: 2.184

4.  Leishmania donovani invasion of the blood in a child with dermal leishmaniasis.

Authors:  N Nuwayri-Salti; S Salman; N M Shahin; J Malak
Journal:  Ann Trop Paediatr       Date:  1999-03

5.  Canine visceral leishmaniasis: asymptomatic infected dogs as a source of L. infantum infection.

Authors:  Abdolali Moshfe; Mehdi Mohebali; Gholamhossein Edrissian; Zabih Zarei; Behnaz Akhoundi; Bahram Kazemi; Shahram Jamshidi; Mahmood Mahmoodi
Journal:  Acta Trop       Date:  2009-07-10       Impact factor: 3.112

Review 6.  Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control.

Authors:  Peter J Hotez; Lorenzo Savioli; Alan Fenwick
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

7.  Risk factors for mortality of children with zoonotic visceral leishmaniasis in Central Tunisia.

Authors:  Khaled Ben Helel; Mohamed Ben Rejeb; Zakia Habboul; Nizar Khattat; Houssain Mejaouel; Houyem Said-Latiri; Belhassen Kaabi; Elyes Zhioua
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

Review 8.  Leishmania species: models of intracellular parasitism.

Authors:  J Alexander; A R Satoskar; D G Russell
Journal:  J Cell Sci       Date:  1999-09       Impact factor: 5.285

9.  Kala-azar epidemiology and control, southern Sudan.

Authors:  Jan H Kolaczinski; Andrew Hope; Jose Antonio Ruiz; John Rumunu; Michaleen Richer; Jill Seaman
Journal:  Emerg Infect Dis       Date:  2008-04       Impact factor: 6.883

10.  Polymerase chain reaction detection of Leishmania DNA in skin biopsy samples in Sri Lanka where the causative agent of cutaneous leishmaniasis is Leishmania donovani.

Authors:  Shalindra Ranasinghe; Renu Wickremasinghe; Sanjeeva Hulangamuwa; Ganga Sirimanna; Nandimithra Opathella; Rhaiza D C Maingon; Vishvanath Chandrasekharan
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-12-11       Impact factor: 2.743

View more
  5 in total

1.  Pediatric visceral leishmaniasis in Tartous, Syria.

Authors:  Ali Othman Hamwi; Ali Abdallatif Mohammad; Sara Othman Hamwi; Razan Abdallatif Mohammad; Kayss Younis Shahin
Journal:  Avicenna J Med       Date:  2020-10-13

2.  Clinical Misdiagnosis of COVID-19 Infection with Confusing Clinical Course.

Authors:  Hamid Eshaghi; Vahid Ziaee; Mahmood Khodabande; Moeinadin Safavi; Elmira Haji Esmaeil Memar
Journal:  Case Rep Infect Dis       Date:  2021-03-31

3.  Insight Into the Long Noncoding RNA and mRNA Coexpression Profile in the Human Blood Transcriptome Upon Leishmania infantum Infection.

Authors:  Sandra Regina Maruyama; Carlos Alessandro Fuzo; Antonio Edson R Oliveira; Luana Aparecida Rogerio; Nayore Tamie Takamiya; Gabriela Pessenda; Enaldo Vieira de Melo; Angela Maria da Silva; Amélia Ribeiro Jesus; Vanessa Carregaro; Helder I Nakaya; Roque Pacheco Almeida; João Santana da Silva
Journal:  Front Immunol       Date:  2022-03-15       Impact factor: 7.561

4.  Immunoinformatics Evaluation of a Fusion Protein Composed of Leishmania infantum LiHyV and Phlebotomus kandelakii Apyrase as a Vaccine Candidate against Visceral Leishmaniasis.

Authors:  Shima Fayaz; Fariborz Bahrami; Pezhman Fard-Esfahani; Parviz Parvizi; Golnaz Bahramali; Soheila Ajdary
Journal:  Iran J Parasitol       Date:  2022 Apr-Jun       Impact factor: 1.217

5.  Non-Leishmania Parasite in Fatal Visceral Leishmaniasis-Like Disease, Brazil.

Authors:  Sandra R Maruyama; Alynne K M de Santana; Nayore T Takamiya; Talita Y Takahashi; Luana A Rogerio; Caio A B Oliveira; Cristiane M Milanezi; Viviane A Trombela; Angela K Cruz; Amélia R Jesus; Aline S Barreto; Angela M da Silva; Roque P Almeida; José M Ribeiro; João S Silva
Journal:  Emerg Infect Dis       Date:  2019-11       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.